Perfil da empresa · Healthcare

Bio-Rad Laboratories Inc

BIO · EUA
Bolsa
EUA
País / Região
USA
Data do IPO
1 de janeiro de 1966
Funcionários
7.450
Preço atual
$282.44
Ao vivo · 22 de junho de 2026
Compra justa
≤ $190
Entrada com margem de segurança
Pontuação de Crescimento Baillie
45/100
Fraco
Valor intrínseco · Faixa em três níveis Preço atual $282.44 Ao vivo · Dentro da faixa de valor intrínseco justo

Faixa de valuation composta · conservador $170–$190 / justo $276–$374 / otimista $466–$510. A $282.44, Dentro da faixa de valor intrínseco justo.

Na publicação $297.09 (2 de julho de 2026)

18 de maio de 2026 Update Needs review

Elliott reportedly builds sizable stake in Bio-Rad

WSJ reported Elliott built a sizable Bio-Rad stake and plans to push for improved share performance.

Possible impact:May affect expectations for governance changes, asset value realization and possible strategic actions.

The Wall Street JournalView source

Automatically summarized from public sources; for context only, not investment advice.

Valor de mercadoUS$ 8,05 bi
Receita (TTM)US$ 2,59 bi
EBITDAUS$ 444,8 mi
Margem líquida6,52%
ROE2,5%
P/L (TTM)49,97
P/L projetado34,01
PEG1,19
LPAUS$ 6,02
Faixa de 52 semanasUS$ 236,73 – US$ 343,12
Preço-alvo dos analistasUS$ 297,00
Recomendação dos analistas4.0 / 5

Dados da EODHD, apresentados na moeda de reporte; apenas para referência, não constitui recomendação de investimento.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

História

Em breveEsta seção está sendo preenchida — volte em breve.

Posição no setor

Em breveEsta seção está sendo preenchida — volte em breve.

Ainda não há análises sobre este ativo no seu idioma.